U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07791823) titled 'Moderate Versus Intensive Lipid-lowering for Events in Asymptomatic Intracranial Stenosis' on Aug. 06.
Brief Summary: It is designed to compare two different strengths of cholesterol-lowering treatment in patients who have narrowing of blood vessels inside the brain (intracranial atherosclerosis) but do not currently have symptoms such as stroke.
The purpose of this study is to find out whether more intensive cholesterol-lowering treatment provides better protection against future vascular events, such as stroke, compared to moderate treatment. Cholesterol, especially LDL cholesterol, is known to contribute to the buildup of plaque...